Investor
This, in addition to the company's Series A round from last year, brings its total amount raised to $77.5 million.
The company plans to use the new funds for global expansion and product development.
The investment will enable the company to expand its international footprint.
The company is currently trading under OWLT on the New York Stock Exchange.
HIMSS21
Reenita Das, partner and SVP for healthcare and life sciences at Frost and Sullivan, said that femtech companies only accounted for 1.8% of total digital health investments in 2020.
Digital diet and wellness company Noom led last quarter's funding with $540 million in Series F investments.
Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.
Once combined, the company will operate as HeartFlow Group and trade on the NYSE under symbol HFLO.
The company currently runs a telehealth platform catering to men's health, fertility health, sexual wellness and skincare.
The Israeli company now has a total of $9 million in venture funding.